Common Cancer Types Found in Boxer Dogs

Boxers are predisposed to a fairly short and specific list of cancers: mast cell tumors above all, lymphoma, primary brain tumors including gliomas, and heart base tumors. They also get cutaneous histiocytoma, which is a tumor but a benign one and usually a false alarm.

The more useful thing to know is that Boxer cancer is not simply "more cancer." Two of these behave differently in Boxers than in other breeds, and they pull in opposite directions. Boxer mast cell tumors skew toward low grade, which is good news. Boxer lymphomas skew heavily toward T-cell, which generally is not. Both facts change what your oncologist will say, and neither shows up in the usual breed-risk lists.

If you have a Boxer, this is what the research supports and what to do about it.

Key Points

Mast cell tumors are the Boxer's signature cancer. In a study of 168,636 dogs in English primary care practice, the overall prevalence was 0.27%, and the Boxer had the highest breed prevalence at 1.95% (Shoop et al., 2015).

Boxers carry the highest risk of low-grade mast cell tumors specifically, at an odds ratio of 6.72, while high-grade risk in that same analysis was concentrated in Shar-Peis and Weimaraners (Śmiech et al., 2018).

Boxers are among the breeds with the highest lymphoma risk, and roughly 90% of Boxer lymphomas are of T-cell origin (Elvers et al., 2015; Modiano et al., 2005).

Boxers have a significantly increased risk of primary intracranial tumors and of glial tumors specifically (Song et al., 2013). In one glioma case series, Boxers made up 44% of the dogs (José-López et al., 2021).

Brachycephalic breeds including the Boxer are predisposed to aortic body tumors at the base of the heart (Kemppainen, 2023).

Predisposition is not prediction. Most Boxers in the largest primary-care dataset available did not have a mast cell tumor.

Every new lump on a Boxer should be aspirated rather than watched. This is the single most useful habit for this breed.

Mast Cell Tumors

This is the one to build a routine around.

Mast cell tumors are the most common malignant skin tumor in dogs, and the Boxer sits at the top of the breed list. Shoop et al. (2015) searched electronic records from English primary-care practices and found mast cell tumors in 0.27% of 168,636 dogs. Broken down by breed, the Boxer had the highest prevalence at 1.95%, ahead of the Golden Retriever at 1.39% and the Weimaraner at 0.85%. That is roughly seven times the overall figure.

Read that number carefully. It describes how many dogs in that population had a diagnosis during the study window, not a lifetime risk. It also means about 98 out of every 100 Boxers in the dataset did not have one.

Now the part that makes Boxer mast cell tumors different. Śmiech et al. (2018) analyzed 492 dogs using the Kiupel two-tier grading system and found the highest risk of low-grade tumors in the Boxer, at an odds ratio of 6.72, with the Pug close behind. The highest risk of high-grade tumors went to the Shar-Pei and the Weimaraner. Boxers get more of these tumors and get proportionally more of the better-behaved kind.

That is genuinely reassuring and it is not permission to relax. A tendency toward low grade across a population says nothing about the specific lump on your specific dog, and high-grade mast cell tumors absolutely occur in Boxers. The grade comes from a pathologist, not from a breed.

What this means practically: run your hands over your Boxer once a month, and when you find something, book an appointment for a fine needle aspirate rather than watching it for a few weeks. Mast cell tumors are notorious for looking like anything. They can be raised, flat, hairless, haired, soft, firm, and they can change size from day to day. Aspiration is quick and it answers the question that looking cannot.

If a mast cell tumor is diagnosed, the numbers that will drive the conversation are grade, mitotic index, and surgical margins. Our article on whether dog cancer can come back covers what those three actually predict.

Lymphoma, and Why the Immunophenotype Matters

Boxers are consistently identified among the breeds at highest risk of lymphoma. The finding that matters more for your dog is which kind.

Modiano et al. (2005) examined lymphoproliferative disease across dog breeds and found that immunophenotype distribution differs sharply by breed, which points to heritable risk rather than chance. Boxers came out skewed toward T-cell disease, and later work summarizing that literature puts roughly 90% of Boxer lymphomas as T-cell in origin (Elvers et al., 2015). Across dogs generally, T-cell lymphoma accounts for something closer to a third of cases.

This matters because B-cell and T-cell lymphoma do not behave the same way. B-cell disease generally responds better and longer to standard multi-agent chemotherapy. T-cell disease tends toward shorter remissions, and some protocols are chosen specifically with T-cell disease in mind.

The action item is simple and specific. If your Boxer is diagnosed with lymphoma, ask whether immunophenotyping has been done, meaning flow cytometry or PARR testing to determine B-cell versus T-cell. In a breed where the odds run this heavily one direction, treating without knowing means treating on an assumption that is probably right and occasionally expensively wrong.

Watch for the practical sign at home: enlarged lymph nodes, most easily felt under the jaw, in front of the shoulders, and behind the knees. They are usually firm, painless, and symmetrical. A Boxer with newly enlarged nodes needs an appointment that week.

Brain Tumors and Gliomas

Boxers turn up in the brain tumor literature more than almost any other breed, and this is the predisposition most owners have never heard about.

Song et al. (2013) reviewed 9,574 dogs examined postmortem over 24 years and identified 435 with intracranial neoplasia. Boxers had a significantly increased risk of primary intracranial tumors, alongside Boston Terriers, Golden Retrievers, French Bulldogs, and Rat Terriers. For glial tumors specifically, the increased-risk list was almost entirely brachycephalic: Boxers, Boston Terriers, French Bulldogs, English Bulldogs, English Toy Spaniels, and Bullmastiffs.

The concentration is striking in clinical case series. In a study of dogs with glioma, 78% were brachycephalic breeds, and Boxers alone accounted for 44% of the cases, 40 out of 91 dogs (José-López et al., 2021).

The sign that matters is seizures. In that same series, seizures were the main presenting complaint in 62% of dogs (José-López et al., 2021). A first seizure in an adult or older Boxer is a different event from a first seizure in a young dog of a low-risk breed, and it deserves a conversation about imaging rather than a wait-and-see anticonvulsant trial alone.

Other signs depend on where the tumor sits: circling, pressing the head against walls, a change in personality, vision loss on one side, weakness or clumsiness on one side, or a head tilt.

None of this means every Boxer seizure is a brain tumor. Epilepsy is far more common overall. It means the pretest probability is higher in this breed, and your veterinarian should know that.

Heart Base Tumors

Aortic body tumors, also called chemodectomas or heart base tumors, arise from chemoreceptor cells near the base of the heart. Brachycephalic breeds including the Boxer and Boston Terrier are predisposed to tumors of the aortic and carotid bodies (Kemppainen, 2023).

The leading explanation is that the flat-faced airway creates chronic low oxygen, which chronically stimulates the chemoreceptor tissue. That is a hypothesis rather than a proven mechanism, and the actual cause remains unknown (Kemppainen, 2023).

Most of these tumors grow slowly and are more often benign than malignant in dogs (Kemppainen, 2023). The problem is rarely spread. It is space. A mass at the base of the heart can press on the atria or the vena cava, cause fluid to collect in the sac around the heart, and produce signs of right-sided heart failure (Kemppainen, 2023).

What you might notice: exercise intolerance, a new cough, fainting or collapse, a swollen abdomen, or labored breathing. Some are found incidentally on chest imaging done for another reason, which is one small argument for not skipping the radiographs your veterinarian suggests.

Cutaneous Histiocytoma: The Lump That Is Usually Fine

Not every Boxer growth is bad news, and this one is worth knowing about specifically because it is the tumor most likely to send an owner into a panic that turns out to be unwarranted.

Cutaneous histiocytoma is a benign tumor of Langerhans cells that occurs mostly in dogs under three, and Boxers are among the breeds reported as overrepresented in more than one source (Torres, 2025; Villalobos, 2026). It appears suddenly, grows fast over the first few weeks, often ulcerates, and then in most cases the dog's own immune system eliminates it over a couple of months.

Rapid growth is the normal behavior of this benign tumor, which means speed of growth cannot be used to sort a histiocytoma from something dangerous. That is the whole argument for aspirating rather than watching, and it applies with more force in a breed that is simultaneously predisposed to mast cell tumors. Our full piece on cutaneous histiocytoma in dogs covers what to expect once it is diagnosed.

What the Numbers Do Not Tell You

Two cautions about breed cancer statistics generally, because Boxer content online is full of confident figures.

You will see claims that some large fraction of Boxers develops cancer, sometimes stated as an annual rate. Those numbers circulate widely without a traceable primary source. The figures in this article are tied to named studies, and they are prevalence and risk estimates in specific populations rather than a lifetime probability for your dog.

Relative risk also gets read as absolute risk. An odds ratio of 6.72 for low-grade mast cell tumors sounds enormous. It means Boxers are several times more likely than the comparison group to develop that tumor, in a population where the tumor is uncommon to begin with. High relative risk of an uncommon event is still an uncommon event.

The honest summary: Boxers have a real, well-documented, type-specific predisposition, and most individual Boxers live full lives. Both things are true and only one of them tends to get repeated.

When to Contact a Veterinarian

Book an appointment for any of the following in a Boxer:

Any new lump or bump anywhere on the body, including one that seems small or is changing size. Ask specifically about a fine needle aspirate.

Enlarged lymph nodes under the jaw, in front of the shoulders, or behind the knees, particularly if several are enlarged at once.

A first seizure at any age, and urgently if seizures cluster or if one lasts more than a few minutes.

Circling, head pressing, disorientation, a change in temperament, apparent vision loss, or weakness on one side of the body.

Exercise intolerance, a new cough, fainting or collapse, a distended abdomen, or labored breathing.

Unexplained weight loss, appetite loss, lethargy that does not resolve, or vomiting and diarrhea that persist.

Seek emergency care for collapse, pale gums, a seizure that will not stop, or sudden severe difficulty breathing.

Questions to Ask Your Veterinarian

Given the breed, what should I be checking at home and how often?

Can we aspirate this lump today rather than monitoring it?

If it is a mast cell tumor, what grade and mitotic index did the pathologist report, and were the margins complete?

If it is lymphoma, has immunophenotyping been done, and is it B-cell or T-cell?

My Boxer had a seizure. Does the breed change your recommendation about imaging?

Would chest radiographs be worth doing at annual visits for this breed?

At what age would you start screening bloodwork or imaging in a Boxer?

Are there Boxer-specific findings in my dog's history that should change our monitoring plan?

Sources

Elvers, I., Turner-Maier, J., Swofford, R., Koltookian, M., Johnson, J., Stewart, C., Zhang, C.-Z., Schumacher, S. E., Beroukhim, R., Rosenberg, M., Thomas, R., Mauceli, E., Getz, G., Breen, M., Lindblad-Toh, K., & Alföldi, J. (2015). Exome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic background. Genome Research, 25(11), 1634-1645. 

José-López, R., Gutierrez-Quintana, R., de la Fuente, C., Manzanilla, E. G., Suñol, A., Pi Castro, D., Añor, S., Sánchez-Masian, D., Fernández-Flores, F., Ricci, E., Marioni-Henry, K., Mascort, J., Matiasek, L. A., Matiasek, K., Brocal, J., Blasco, E., Pumarola, M., & Rodenas, S. (2021). Clinical features, diagnosis, and survival analysis of dogs with glioma. Journal of Veterinary Internal Medicine, 35(4), 1902-1917. 

Kemppainen, R. J. (2023). Chemodectomas in animals. Merck Veterinary Manual. https://www.merckvetmanual.com/endocrine-system/neuroendocrine-tumors/chemodectomas-in-animals (Full review July 2023; last updated September 2024)

Modiano, J. F., Breen, M., Burnett, R. C., Parker, H. G., Inusah, S., Thomas, R., Avery, P. R., Lindblad-Toh, K., Ostrander, E. A., Cutter, G. C., & Avery, A. C. (2005). Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk. Cancer Research, 65(13), 5654-5661. 

Shoop, S. J. W., Marlow, S., Church, D. B., English, K., McGreevy, P. D., Stell, A. J., Thomson, P. C., O'Neill, D. G., & Brodbelt, D. C. (2015). Prevalence and risk factors for mast cell tumours in dogs in England. Canine Genetics and Epidemiology, 2, Article 1. 

Śmiech, A., Ślaska, B., Łopuszyński, W., Jasik, A., Bochyńska, D., & Dąbrowski, R. (2018). Epidemiological assessment of the risk of canine mast cell tumours based on the Kiupel two-grade malignancy classification. Acta Veterinaria Scandinavica, 60, Article 70. 

Song, R. B., Vite, C. H., Bradley, C. W., & Cross, J. R. (2013). Postmortem evaluation of 435 cases of intracranial neoplasia in dogs and relationship of neoplasm with breed, age, and body weight. Journal of Veterinary Internal Medicine, 27(5), 1143-1152. 

Torres, S. M. F. (2025). Histiocytic proliferative disorders. In Small and large animal dermatology handbook (Vol. 3). University of Minnesota Libraries Publishing. https://open.lib.umn.edu/animaldermatology3/chapter/1f-histiocytic-proliferative-disorders/

Villalobos, A. E. (2026, June). Lymphocytic, histiocytic, and related cutaneous tumors in animals. Merck Veterinary Manual. https://www.merckvetmanual.com/integumentary-system/tumors-of-the-skin-and-soft-tissues/lymphocytic-histiocytic-and-related-cutaneous-tumors-in-animals